AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • February 29th, 2024 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations
This AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Amendment”), entered into on July 27, 2023 (the “Effective Date”), is by and among Maravai LifeSciences Holdings, Inc., a Delaware corporation (“Parent”), Maravai Intermediate Holdings, LLC, a Delaware limited liability company (“Employer”), and Carl W. Hull (“Executive”).
SECOND AMENDMENT TO LEASE AGREEMENTLease Agreement • February 29th, 2024 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations
This SECOND AMENDMENT TO LEASE AGREEMENT (“Amendment”) is entered into as of October 1, 2022 (“Effective Date”), by and between 10240 FLANDERS INVESTORS LLC, a Delaware limited liability company (“Landlord”), and TRILINK BIOTECHNOLOGIES, LLC, a Delaware limited liability company (“Tenant”), with reference to the facts set forth in the Recitals below.
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • February 29th, 2024 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations
This FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is dated as of August 11, 2021 and is entered into by and among MARAVAI INTERMEDIATE HOLDINGS, LLC, a Delaware limited liability company (“Parent Borrower”), and MORGAN STANLEY SENIOR FUNDING, INC. (“MS”), as administrative agent for the Lenders (in such capacity, the “Administrative Agent”), and amends that certain Credit Agreement, dated as of October 19, 2020, by and among Parent Borrower, CYGNUS TECHNOLOGIES, LLC, a Delaware limited liability company (“Cygnus”), TRILINK BIOTECHNOLOGIES, LLC, a Delaware limited liability company (“TriLink”), Vector Laboratories, Inc., a California corporation (“Vector”; and together with the Parent Borrower, Cygnus and TriLink, the “Borrowers” and each, a “Borrower”), MARAVAI TOPCO HOLDINGS, LLC, a Delaware limited liability company (“Holdings”), each lender from time to time party thereto (collectively, the “Lenders”), each L/C Issuer party hereto, the Administrative Agent and MS, as Colla
LEASE AGREEMENT BETWEEN CIGG, LLC Landlord AND CYGNUS TECHNOLOGIES, LLC Tenant DATED: June 11, 2021Lease Agreement • February 29th, 2024 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations • North Carolina
THIS LEASE (this “Lease”) is entered into this June 11, 2021 (the date of execution of this Lease by authorized parties of Landlord and Tenant shall be the “Effective Date”), by and between CIGG, LLC, a North Carolina limited liability company, having its principal place of business at 3514 South College Road, Wilmington, North Carolina, as landlord (“Landlord”), and CYGNUS TECHNOLOGIES, LLC, a Delaware limited liability company, authorized to conduct business in North Carolina, 4332 Southport Supply Rd, SE, Southport; NC 28461, as tenant (“Tenant”).
LEASE AGREEMENT BETWEEN 10240 FLANDERS INVESTORS LLC, a Delaware limited liability company (LANDLORD) AND TRILINK BIOTECHNOLOGIES, LLC, a Delaware limited liability company (TENANT) August 6, 2021 10240-10247 FLANDERS COURT SAN DIEGO, CALIFORNIALease Agreement • February 29th, 2024 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations
FIRST AMENDMENT TO LEASE AGREEMENTLease Agreement • February 29th, 2024 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations
This FIRST AMENDMENT TO LEASE AGREEMENT (“Amendment”) is entered into as of October 14, 2021 (“Effective Date”), by and between 10240 FLANDERS fNVESTORS LLC, a Delaware limited liability company (“Landlord”), and TRILINK BIOTECHNOLOGIES, LLC, a Delaware limited liability company (“Tenant”), with reference to the facts set forth in the Recitals below.
